397 Fifty two-week efficacy and safety results from...

The Journal of Investigative Dermatology 2017 / 10 Vol. 137; Iss. 10

397 Fifty two-week efficacy and safety results from SPIRIT-P1: A Phase 3 study of ixekizumab in patients with active psoriatic arthritis

Mease, P., Okada, M., Kishimoto, M., Shuler, C., Carlier, H., Lin, C., Mou, J., Moriarty, S.R., Lee, C., Gladman, D., Satler, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
137
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2017.07.592
Date:
October, 2017
File:
PDF, 431 KB
english, 2017
Conversion to is in progress
Conversion to is failed